Niagen BioScience

Niagen BioScience has been a member of Linktree for 1 year and joined in March 2025. The social media accounts linked to from Niagen BioScience are: • Facebook • Instagram • YouTube • LinkedIn • X Besides social media accounts, niagenbioscience has populated their site with: • East Coast IDEAS Investor Conference Live Stream • Cannes Lions 2026 | Monks • Fireside Chat with Niagen Bioscience – Longevity as the Next Consumer Revolution • Tru Niagen Review (2026): Expert Approved | Fortune • Is Niagen the Best NAD+ Precursor? Science Says Yes - Los Angeles Times • Niagen Bioscience Launches Pharmaceutical Program for Accelerated Aging and Rare Genetic Diseases • Niagen Bioscience CEO Rob Fried to Participate in Virtual Fireside Chat to Discuss Pharmaceutical Strategy on July 15, 2026 • Science of NAD+: Restoring Cellular Energy & Healthspan - Los Angeles Times • Niagen Bioscience Receives Exclusive U.S. FDA Rare Pediatric Disease (RPD) Designation and European Medicines Agency Orphan Medicinal Product Designation (OMPD) for NB4168 for the Treatment of Ataxia Telangiectasia (A-T) • Niagen Bioscience Appoints Abhijit Kale, Ph.D., as Senior Director of Global External Research • Niagen Bioscience to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026 • Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference • Register for the Niagen Bioscience fireside chat webcast - Canaccord Genuity’s 46th Annual Growth Conference • Niagen Bioscience Announces a Newly Published Analysis of Past Clinical Studies Demonstrating Niagen® (Patented Nicotinamide Riboside, NR) Supplementation Improved a Muscle-Specific Marker of Biological Aging • Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168 • Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results • Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence • Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference • Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club • Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit • Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference • Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science • There’s Good News and Bad News About NAD+, the Buzziest Wellness Supplement • Niagen launches telehealth NAD+ injection platform • Niagen Bioscience Announces Participation in Upcoming Investor Conferences • Niagen Bioscience, Inc. Reports First Quarter 2026 Financial Results • The new era of life sciences • Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering • Inside Tru Niagen’s Expansion Into NAD+ Beauty And Skincare • Niagen Bioscience innovating NAD+-based therapies from healthy aging to pediatric orphan diseases - BioTuesdays • Niagen Bioscience Adds Olympia Pharmaceuticals to 503B Compounding Partner Network for Niagen Plus™ • Live Foreverish Podcast Episode • What Is Nicotinamide Riboside (NR)? How It Increases NAD Levels - Los Angeles Times • How Tru Niagen Built Niagen Bioscience’s NAD+ Longevity Business - Los Angeles Times • Niagen Bioscience to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 • Niagen Bioscience Collaborates with USP to Establish First-Ever USP Monograph for Nicotinamide Riboside Chloride (NRCl), the Patented Form in Niagen® • Niagen Bioscience Announces First Cruise Ship Clinic Partnership with OneSpaWorld, Bringing the NAD-Boosting Benefits of Niagen IV to the High Seas • NAD for Health: Opportunities & Challenges • Niagen Bioscience Increases Share Repurchase Program to $20 Million • Niagen Bioscience to Present at the 38th Annual ROTH Conference • Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies • Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® • Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 • Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction • Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen® • Intravenous infusion of nicotinamide adenine dinucleotide (NAD+) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting - PubMed • How To Boost NAD Levels To Fight Inflammation, Improve Recovery, and Slow Aging | Dr. Charles Brenner • Going the Distance: US Olympic… - Pregnantish - Apple Podcasts • The divergent effects of nicotinamide riboside and high-intensity exercise training on skeletal muscle epigenetic aging • The NAD-brain pharmacokinetic study of NAD augmentation in blood and brain using oral precursor supplementation: iScience • 541: Can a Pill Help You Live … - The Genius Life - Apple Podcasts • 5 Supplements Women over 50 Should Consider • Niagen Bioscience Expands HSA/FSA Access for Tru Niagen®, the Leading NAD+ Supplement in the U.S.* • The Best Products from the Most Popular Wellness Brands of 2025 - Athletech News • Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen’s University Belfast • BlueMatrix • CRN Announces Board of Directors Election Results; Association Leadership in Place to Address 2026 Challenges and Opportunities for the Dietary Supplement and Functional Food Industry | Council for Responsible Nutrition • The Wild West World Of Supplements—What Consumers Should Know • Exclusive | Buzzy NAD+ treatment boosts energy, better sleep and recovery | New York Post • Long Covid Podcast- Cellular Recharge: Can N… • Exclusive: NAD+ supplement leader Tru Niagen enters the beauty supplement market, targeting the ‘much younger’ wellness consumer • Healthcare Practitioner Webinar Series – Episode 30 - Exploring Niagen in Individuals with Long COVID Symptoms - Demio • Niagen Bioscience Launches Tru Niagen® Beauty — The First NAD+ Skincare Supplement in the U.S. Featuring Niagen® (Patented Nicotinamide Riboside) • Niagen Bioscience Announces Results from First-Ever Randomized Controlled Trial Exploring Niagen (Patented Nicotinamide Riboside, NR) Supplementation in Long COVID • Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial - eClinicalMedicine • Niagen Bioscience Announces $10 Million Share Repurchase Program • Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook • NAD+ market analysis: From hype to reality check • Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth • niagenbioscience.com • truniagen.com • Tru Niagen Instagram • Tru Niagen TikTok • Tru Niagen Facebook • Tru Niagen YouTube • Tru Niagen on X • niagenplus.com • Niagen Plus Instagram • Niagen Plus TikTok • Niagen Plus Facebook • Niagen Plus on X